MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
MDT
89.97
+0.71%↑
VEEV
275.84
-1.9%↓
A
123.3
-0.67%↓
WBA
11.51
-0.35%↓
HQY
94.45
-2.78%↓
24h
Current
Min
3.88
Max
4.46
Income | 7.3M -23M |
---|---|
Sales | -527K 30M |
EPS | -2.77 |
Profit margin | -78.168 |
Employees | 279 |
EBITDA | -14M -33M |
Recommendations | Buy |
---|---|
12 Months Forecast | +288% upside |
Market Cap | -16M 37M |
---|---|
Previous open | 18.76 |
Previous close | 4.15 |
By Acuity
50%
50%
131 / 376 Ranking in Healthcare
By Trading Central
Confidence
Bullish Evidence
5.9501 / 7.66 Support & Resistance
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
11 lip 2025, 22:19 UTC
FCC Approves U.S. Cellular Sale to T-Mobile
DJ
Read
11 lip 2025, 17:28 UTC
SharpLink Gaming Gains on Ethereum Purchase
DJ
Read
11 lip 2025, 16:57 UTC
BASF Cuts Outlook on Global Economy Uncertainty
DJ
Read
12 lip 2025, 17:01 UTC
That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com
DJ
Read
12 lip 2025, 14:53 UTC
That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com
DJ
Read
12 lip 2025, 02:24 UTC
Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update
DJ
Read
12 lip 2025, 02:05 UTC
Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ
DJ
Read
12 lip 2025, 02:05 UTC
Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ
DJ
Read
12 lip 2025, 02:05 UTC
Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ
DJ
Read
11 lip 2025, 21:45 UTC
Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk
DJ
Read
11 lip 2025, 19:46 UTC
Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com
DJ
Read
11 lip 2025, 19:45 UTC
Crude Futures Post Back-to-Back Weekly Gains -- Market Talk
DJ
Read
11 lip 2025, 19:05 UTC
U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk
DJ
Read
11 lip 2025, 18:18 UTC
Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk
DJ
Read
11 lip 2025, 17:35 UTC
Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk
DJ
Read
11 lip 2025, 17:26 UTC
U.S. Oil Rig Count Down by 1 to 424 -- Market Talk
DJ
Read
11 lip 2025, 16:53 UTC
Crude Futures Add to Early Gains -- Market Talk
DJ
Read
11 lip 2025, 16:42 UTC
BASF Cuts Outlook on Global Economic Uncertainty
DJ
Read
11 lip 2025, 16:08 UTC
Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk
DJ
Read
11 lip 2025, 16:05 UTC
BASF Will Publish Half-Year Results on July 30
DJ
Read
11 lip 2025, 16:04 UTC
Global Equities Roundup: Market Talk
DJ
Read
11 lip 2025, 16:04 UTC
Senior Housing Shortage Gives REITs Pricing Power -- Market Talk
DJ
Read
11 lip 2025, 16:03 UTC
BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties
DJ
Read
11 lip 2025, 16:02 UTC
BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025
DJ
Read
11 lip 2025, 16:01 UTC
BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025
DJ
Read
11 lip 2025, 16:00 UTC
BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025
DJ
Read
11 lip 2025, 15:59 UTC
BASF Cuts 2025 Earnings View
DJ
Read
11 lip 2025, 15:58 UTC
Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com
DJ
Read
11 lip 2025, 15:57 UTC
BASF 2Q EBIT Before Special Items EUR810M
DJ
Read
11 lip 2025, 15:54 UTC
BASF: Analysts Had Expected 2Q Sales of EUR15.80B
DJ
Read
Price change
By TipRanks
12 Months Forecast
Average 19.4 USD 288%
High 42 USD
Low 4 USD
Based on 5 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.
By TipRanks
Buy
5 ratings
3
Buy
1
Hold
1
Sell
Based on 5 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.
By Trading Central
Short Term
Bullish Evidence
Recent bullish events outweigh bearish events.
Intermediate Term
Strong Bearish Evidence
All events are bearish.
Long Term
No Evidence
There are no events.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$